Direct acting antiviral treatment of chronic hepatitis C in Denmark: factors associated with and barriers to treatment initiation

Christina Sølund, Sofie Hallager, Martin S Pedersen, Ulrik Fahnøe, Anja Ernst, Henrik B Krarup, Birgit T Røge, Peer B Christensen, Alex L Laursen, Jan Gerstoft, Erika Bélard, Lone G Madsen, Kristian Schønning, Anders G Pedersen, Jens Bukh, Nina Weis, DANHEP group, Henrik Krarup (Member of study group), Jesper Bach Hansen (Member of study group), Lone Mygind (Member of study group)

Research output: Contribution to journalJournal articleResearchpeer-review

18 Citations (Scopus)
Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume53
Issue number7
Pages (from-to)849-856
Number of pages8
ISSN0036-5521
DOIs
Publication statusPublished - 2018

Keywords

  • DAA
  • Direct Acting Antivirals
  • HCV
  • barriers to treatment
  • factors associated with treatment
  • hepatitis C virus
  • liver cancer
  • liver disease
  • treatment initiation
  • Humans
  • Middle Aged
  • Male
  • Liver Cirrhosis/epidemiology
  • Treatment Failure
  • Hepatitis C, Chronic/complications
  • Adult
  • Female
  • Drug Administration Schedule
  • Hepacivirus/genetics
  • Risk Factors
  • Logistic Models
  • Denmark/epidemiology
  • Antiviral Agents/therapeutic use
  • Patient Compliance
  • Sustained Virologic Response
  • Cohort Studies
  • Practice Guidelines as Topic

Cite this